PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 12706118-5 2003 We have found up-regulated levels of the cyclin-dependent kinase 2 (cdk2) protein in HDF expressing 143(ala) mutant p53 as compared to senescent controls, together with an increase in p21-free cdk2 which, in conjunction with cyclin E, is able to form an active kinase which can phosphorylate the retinoblastoma protein. Alanine 104-107 cyclin dependent kinase 2 Homo sapiens 68-72 14506259-3 2003 The catalytic efficiency of CDK2-cyclin A is impaired 2000-, 10-, and 150-fold, when Pro+1, Lys+2, or Lys+3, respectively, is substituted with Ala in a short synthetic peptide substrate. Alanine 143-146 cyclin dependent kinase 2 Homo sapiens 28-32 17804818-5 2007 When a Cdk2 phosphorylation site within Mps1 (T468) is mutated to alanine, Mps1 cannot accumulate at centrosomes or participate in centrosome duplication. Alanine 66-73 cyclin dependent kinase 2 Homo sapiens 7-11 12706118-5 2003 We have found up-regulated levels of the cyclin-dependent kinase 2 (cdk2) protein in HDF expressing 143(ala) mutant p53 as compared to senescent controls, together with an increase in p21-free cdk2 which, in conjunction with cyclin E, is able to form an active kinase which can phosphorylate the retinoblastoma protein. Alanine 104-107 cyclin dependent kinase 2 Homo sapiens 41-66 11438644-2 2001 Alanine scanning mutagenesis of the Cy motif of the cdk inhibitor p21 revealed that the conserved arginine or leucine (constituting the conserved RXL sequence) was important for p21"s ability to inhibit cyclin E-cdk2 activity. Alanine 0-7 cyclin dependent kinase 2 Homo sapiens 212-216 11502743-6 2001 Importantly, rather than inhibiting it, Cyclin A-Cdk2 stimulated the initiation activity of pol-prim containing a triple N-terminal alanine mutant of the p180 subunit. Alanine 132-139 cyclin dependent kinase 2 Homo sapiens 49-53 10884347-5 2000 An alanine mutation at any one of four key positions abrogates the efficacy of a synthetic peptide containing this motif as an inhibitor of cyclin A-cdk2 phosphorylation of p53 protein. Alanine 3-10 cyclin dependent kinase 2 Homo sapiens 149-153 10995387-12 2000 Importantly, mutation of Cdk2 phosphorylation sites to alanine abrogates the ability of p220 to activate the histone H2B promoter. Alanine 55-62 cyclin dependent kinase 2 Homo sapiens 25-29 7784076-2 1995 To investigate the molecular basis of the interaction between these proteins and the cyclin-dependent kinases (CDKs), we performed a systematic mutagenesis of the CKI family member p21Cip1 using the alanine-scanning strategy. Alanine 199-206 cyclin dependent kinase 2 Homo sapiens 111-115 10095772-7 1999 Mutation of one of these residues (T524) to alanine diminished the ability of B-Myb to promote transcription of a reporter gene, suggesting that phosphorylation of B-Myb at this site is important for the regulation of its activity by cyclin A/Cdk2. Alanine 44-51 cyclin dependent kinase 2 Homo sapiens 243-247 7624134-8 1995 Mutation of serine 315 of p53 to alanine (p53-S315A) abolished phosphorylation by cdk2 kinase. Alanine 33-40 cyclin dependent kinase 2 Homo sapiens 82-86 1396589-5 1992 Replacement of T160 with alanine abolishes the kinase activity of CDK2, indicating that phosphorylation at this site (as in CDC2) is required for kinase activity. Alanine 25-32 cyclin dependent kinase 2 Homo sapiens 66-70 23853094-5 2013 Consistent with our previous demonstration that CDK2 negatively regulates Treg function, we find that mutation of the serine or threonine at each CDK motif to alanine (S/T A) results in enhanced Foxp3 protein stability in CD4(+) T cells. Alanine 159-166 cyclin dependent kinase 2 Homo sapiens 48-52